CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Deferred Tax Liabilities, Financing Arrangements
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Deferred Tax Liabilities, Financing Arrangements of $898.00 thousand as of 2018-12-29, per its 10-K filed 2019-02-13.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesFinancingArrangements · last filed 2019-02-13
- 2018-12-29: Deferred Tax Liabilities, Financing Arrangements $898.00K.
- 2017-12-30: Deferred Tax Liabilities, Financing Arrangements $429.00K.
- 2016-12-31: Deferred Tax Liabilities, Financing Arrangements $854.00K.
- 2015-12-26: Deferred Tax Liabilities, Financing Arrangements $0.00.
| Period end | Deferred Tax Liabilities, Financing Arrangements |
|---|---|
| 2018-12-29 | $898.00K 10-K · filed 2019-02-13 |
| 2017-12-30 | $429.00K 10-K · filed 2019-02-13 |
| 2016-12-31 | $854.00K 10-K · filed 2018-02-13 |
| 2015-12-26 | $0.00 10-K · filed 2017-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |